| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.3 | 0.06 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.31 | 0.06 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |